Smart science to improve lives™
Paris skyline

France

Croda France opened in Paris in 1976 and is today located near Versailles, with commercial, logistics, accounting and administrative teams plus a local warehouse. Our manufacturing site in Chocques not only supports our customers but also local biodiversity through more than 50,000 bees onsite, with their natural honey shared with employees.

France is also home to Crodarom and Sederma, within our Beauty Actives business. Founded in 1998, Crodarom manufactures innovative plant extracts for personal care and industrial applications. Founded in 1964, Sederma develops active ingredients and innovative concepts for cosmetics. With a high performance claim substantiation laboratory, powerful in vitro, ex vivo and in vivo tests prove the efficacy of products. 

Our fine fragrance business Parf’Ex, acquired by Croda subsidiary Iberchem in June 2021, is headquartered in Grasse.

Our dynamic teams in France are highly supportive of local charities and communities.

Croda France SAS

1, avenue de Westphalie
78180 Montigny-Le-Bretonneux
France
Tel:  +33 1 301 39430

Croda Chocques S.A.S.

1, rue de Lapugnoy
62920
Chocques
France
Tel:  +33 3 21 61 84 00

Crodarom S.A.S

Crodarom SAS
Parc d'Activites Les Plaines
F 48230
Chanac
France
Tel:  +33 4 6648 2027

Sederma S.A.S.

Sederma SAS
29 rue du Chemin Vert
78612 Le Perray en Yvelines Cedex
France
Tel:  +33 1 3484 1010

Parf'ex SA

Parc d'activités les Bois de Grasse
51, avenue Louison
Bobet 06130
GRASSE
France
+33 (0)4 92 42 42 52

Alban Muller - Fontenay

9, rue Jean Monnet
28630 FONTENAY SUR EURE

Alban Muller - Vincennes

8, rue Charles Pathé
94000 Vincennes
France

Further reading

Sustainability expert Aris Vrettos joins Croda

The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...

U.S. Government to support expansion of Croda lipid systems capability

Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines

Launch of first report on biotechnology opportunities in the personal care market

27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
Danuta Gray

Appointment of Chair Designate

22 September 2023: We are pleased to announce the appointment of Danuta Gray as a Non-Executive Director and Chair Designate